1. Home
  2. BAER vs ONCY Comparison

BAER vs ONCY Comparison

Compare BAER & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bridger Aerospace Group Holdings Inc.

BAER

Bridger Aerospace Group Holdings Inc.

HOLD

Current Price

$1.92

Market Cap

113.0M

Sector

Finance

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.75

Market Cap

107.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAER
ONCY
Founded
2014
1998
Country
United States
Canada
Employees
235
N/A
Industry
Blank Checks
Pharmaceuticals and Biotechnology
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
113.0M
107.3M
IPO Year
N/A
2002

Fundamental Metrics

Financial Performance
Metric
BAER
ONCY
Price
$1.92
$0.75
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$5.00
$7.33
AVG Volume (30 Days)
345.3K
1.5M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$16.47
N/A
Revenue Next Year
N/A
$2,505.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.47
$0.75
52 Week High
$3.44
$1.51

Technical Indicators

Market Signals
Indicator
BAER
ONCY
Relative Strength Index (RSI) 49.18 35.51
Support Level $1.58 N/A
Resistance Level $1.93 $1.06
Average True Range (ATR) 0.12 0.06
MACD 0.00 -0.01
Stochastic Oscillator 51.71 1.97

Price Performance

Historical Comparison
BAER
ONCY

About BAER Bridger Aerospace Group Holdings Inc.

Bridger Aerospace Group Holdings Inc operates as an aerial firefighting company. It provides aerial wildfire surveillance, relief and suppression, and aerial firefighting services using next-generation technology and environmentally friendly and sustainable firefighting methods. Its revenues is derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation services. The company's portfolio is organized across three offerings namely : Fire Suppression; Aerial Surveillance; and Maintenance, Repair and Overhaul (MRO). The company operates as a single operating segment. Its revenues are derived from aerial wildfire management, relief and suppression and the delivery of specialty aviation service. Geographically, it operates in Spain and United States.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: